Effect of bupropion on nicotine self-administration in rats
- 296 Downloads
Rationale and objective
The mechanisms underlying the therapeutic efficacy of bupropion as a smoking cessation agent are unknown. Bupropion inhibits monoamine uptake as well as neuronal nicotinic receptor (nAChR) function. The present study compared effects of bupropion on nicotine self-administration to those of other stimulant drugs (methamphetamine and apomorphine) that lack nAChR activity in order to determine its mechanism of action. To determine the specificity of bupropion-induced changes in nicotine self-administration, the ability of bupropion to alter sucrose-maintained responding or amphetamine self-administration was determined.
In nicotine and amphetamine self-administration and sucrose-maintained responding experiments, rats responded for nicotine (0.01 or 0.02 mg/kg per infusion, IV), amphetamine (0.2 mg/kg per infusion, IV) and sucrose pellets (45 mg), respectively, on a fixed ratio 5 schedule. Once responding stabilized, rats were pretreated 15 min before the session with bupropion (1–78 mg/kg) or vehicle. The ability of methamphetamine (0.3–3 mg/kg) or apomorphine (0.01–0.2 mg/kg) to alter responding for nicotine (0.02 mg/kg per infusion, IV) was determined.
Bupropion produced a biphasic dose-response pattern at both nicotine infusion doses, increasing infusions at low bupropion doses and decreasing infusions at high bupropion doses. Methamphetamine produced a similar biphasic pattern, whereas apomorphine only decreased nicotine infusions at high doses. Bupropion dose-dependently decreased responding for sucrose and amphetamine.
These results suggest that high bupropion doses decrease responding nonspecifically; whereas low bupropion doses selectively increase responding for nicotine. The increase in nicotine self-administration is likely due to inhibition of dopamine and norepinephrine transporters, combined with inhibition of nAChRs.
KeywordsAmphetamine Apomorphine Bupropion Methamphetamine Nicotine Self-administration
This research was supported by the Pharmacia Corporation (Kalamazoo, Mich., USA). A.S. Rauhut was supported by a National Institutes of Health, National Research Service Award (T32 DA07304) from the National Institute on Drug Abuse. The authors wish to thank Laura Fenton, Thomas Green and Brenna Shortridge for their excellent technical assistance.
- Andersen PH, Jansen JA (1990) Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur J Pharmacol [Mol Pharmacol Sect] 188:335–347Google Scholar
- Balfour DJK, Benwell MEM (1993) The role of brain dopamine systems in the psychopharmacological responses to nicotine. Asia Pac J Pharmacol 8:153–167Google Scholar
- Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ and Johnston EC (1997) Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4, and hα7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 280:346–356PubMedGoogle Scholar
- Griffith JD, Carina J, Griffith C, Miller LL (1983) Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry 45:206–208Google Scholar
- Goldstein MG (1998) Bupropion sustained release and smoking cessation. J Clin Psychiatry 59:66–72Google Scholar
- Heal DJ, Frankland ATJ, Gosden J, Hutchins LJ, Prow MR, Luscombe GP, Buckett WR (1992) A comparison of the effects of sibutramine hydrochloride, bupropion, and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine. Psychopharmacology 107:303–309PubMedGoogle Scholar
- McKearney JW (1982) Effects of dopamine uptake inhibitors on schedule-controlled behavior in squirrel monkey. Psychopharmacology 78:377–379Google Scholar
- Nomikos GC, Damsma G, Wenkstern D, Fibiger HC (1992) Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 7:7–14Google Scholar
- Prada JA, Goldberg SR (1985) Effects of caffeine or nicotine pretreatments on nicotine self-administration by the squirrel monkey. Pharmacologist 27:226Google Scholar
- Randzius A, Carriero NJ, Weinhold LL, Gorelick DA, Henningfield JE (1997) Changes in cigarette smoking not observed following repeated cocaine self-administration. Exp Clin Psychopharmacol 5:51–53Google Scholar
- Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 148:33–40Google Scholar
- Shoaib M, Zubaran C, Stolerman IP (2000) Antagonism of stimulus properties of nicotine by dihydro-β-erythroidine (DHβE) in rats. Psychopharmacology 149:140–146Google Scholar
- Shoaib M, Sidhpura N, Shafait S (2003) Investigating the actions of bupropion on dependence-related effects of nicotine in rats. Psychopharmacology 165:405–412Google Scholar
- Workman EA, Short DD (1993) Atypical antidepressants versus imipramine in the treatment of major depression—a meta-analysis. J Clin Psychiatry 54:5–12Google Scholar